个人中心 - 老虎社区

打铁不如李铁

IP属地：广东

帖子 · 242帖子 · 242
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 打铁不如李铁打铁不如李铁
  ·01-16 12:21
  $台积电(TSM)$ 创记录的台积电
  222 评论
  1
  分享
  举报
- 打铁不如李铁打铁不如李铁
  ·01-16 12:21
  $果下科技(02655)$ 果下继续走暴涨模式，外资不讲理的扫货加大了散户抢筹的难度
  11 评论
  1
  分享
  举报
- 打铁不如李铁打铁不如李铁
  ·01-16 12:16
  $中国电信(00728)$ 一直向下的节奏就不对了吧
  34 评论
  1
  分享
  举报
- 打铁不如李铁打铁不如李铁
  ·01-16 12:15
  $同源康医药-B(02410)$ 同源康医药于2025年底完成肿瘤事业部组建，核心成员来自阿斯利康、恒瑞医药，具备肺癌领域学术推广与医院准入经验
  32 评论
  1
  分享
  举报
- 打铁不如李铁打铁不如李铁
  ·01-14 15:56
  $佑驾创新(02431)$ 无一例个今天集体调整
  68 评论
  1
  分享
  举报
- 打铁不如李铁打铁不如李铁
  ·01-14 15:55
  $黑芝麻智能(02533)$ 上周看9号数据融资买入2180万元，为近半年单日最高，反映市场对出口突破与资金用途高度认可
  130 评论
  1
  分享
  举报
- 打铁不如李铁打铁不如李铁
  ·01-08
  $中国南方航空股份(01055)$ 随时有可能会来个向上爆发
  149 评论
  1
  分享
  举报
- 打铁不如李铁打铁不如李铁
  ·01-08
  $中慧生物-B(02627)$ 冻干人用狂犬病疫苗III期试验持续推进，覆盖Essen、Zagreb及简易四针方案，研发进入关键数阶段
  125 评论
  1
  分享
  举报
- 打铁不如李铁打铁不如李铁
  ·01-06
  $Bakkt Holdings, Inc.(BKKT)$ 触底必须得反弹
  146 评论
  1
  分享
  举报
- 打铁不如李铁打铁不如李铁
  ·01-06
  $晶泰控股(02228)$ 2025年，中国医药健康领域迎来从“量变”到“质变”的关键跃升，是政策、技术与产业协同成效，AI制药打破研发“不可能三角”，晶泰2026将迎来史上最佳发展时机
  441 评论
  1
  分享
  举报
暂无关注

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4193625296607780","uuid":"4193625296607780","gmtCreate":1730522161499,"gmtModify":1739850751500,"name":"打铁不如李铁","pinyin":"dtbrltdatieburulitie","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":11,"tweetSize":242,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":522437736534232,"gmtCreate":1768537318365,"gmtModify":1768537321561,"author":{"id":"4193625296607780","authorId":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4193625296607780","idStr":"4193625296607780"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/TSM\">$台积电(TSM)$&nbsp;</a> 创记录的台积电","listText":"<a href=\"https://laohu8.com/S/TSM\">$台积电(TSM)$&nbsp;</a> 创记录的台积电","text":"$台积电(TSM)$ 创记录的台积电","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/522437736534232","isVote":1,"tweetType":1,"viewCount":222,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":522245131257256,"gmtCreate":1768537285705,"gmtModify":1768537288002,"author":{"id":"4193625296607780","authorId":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4193625296607780","idStr":"4193625296607780"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02655\">$果下科技(02655)$ </a> 果下继续走暴涨模式，外资不讲理的扫货加大了散户抢筹的难度","listText":"<a href=\"https://laohu8.com/S/02655\">$果下科技(02655)$ </a> 果下继续走暴涨模式，外资不讲理的扫货加大了散户抢筹的难度","text":"$果下科技(02655)$ 果下继续走暴涨模式，外资不讲理的扫货加大了散户抢筹的难度","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/522245131257256","isVote":1,"tweetType":1,"viewCount":11,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":522244067083512,"gmtCreate":1768536961184,"gmtModify":1768536964339,"author":{"id":"4193625296607780","authorId":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4193625296607780","idStr":"4193625296607780"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/00728\">$中国电信(00728)$&nbsp;</a> 一直向下的节奏就不对了吧","listText":"<a href=\"https://laohu8.com/S/00728\">$中国电信(00728)$&nbsp;</a> 一直向下的节奏就不对了吧","text":"$中国电信(00728)$ 一直向下的节奏就不对了吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/522244067083512","isVote":1,"tweetType":1,"viewCount":34,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":522243669239264,"gmtCreate":1768536939112,"gmtModify":1768536942700,"author":{"id":"4193625296607780","authorId":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4193625296607780","idStr":"4193625296607780"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康医药于2025年底完成肿瘤事业部组建，核心成员来自阿斯利康、恒瑞医药，具备肺癌领域学术推广与医院准入经验","listText":"<a href=\"https://laohu8.com/S/02410\">$同源康医药-B(02410)$ </a> 同源康医药于2025年底完成肿瘤事业部组建，核心成员来自阿斯利康、恒瑞医药，具备肺癌领域学术推广与医院准入经验","text":"$同源康医药-B(02410)$ 同源康医药于2025年底完成肿瘤事业部组建，核心成员来自阿斯利康、恒瑞医药，具备肺癌领域学术推广与医院准入经验","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/522243669239264","isVote":1,"tweetType":1,"viewCount":32,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":521667755230400,"gmtCreate":1768377380834,"gmtModify":1768377382485,"author":{"id":"4193625296607780","authorId":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4193625296607780","idStr":"4193625296607780"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02431\">$佑驾创新(02431)$ </a> 无一例个今天集体调整","listText":"<a href=\"https://laohu8.com/S/02431\">$佑驾创新(02431)$ </a> 无一例个今天集体调整","text":"$佑驾创新(02431)$ 无一例个今天集体调整","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/521667755230400","isVote":1,"tweetType":1,"viewCount":68,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":521667114279256,"gmtCreate":1768377331571,"gmtModify":1768377334310,"author":{"id":"4193625296607780","authorId":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4193625296607780","idStr":"4193625296607780"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02533\">$黑芝麻智能(02533)$&nbsp;</a> 上周看9号数据融资买入2180万元，为近半年单日最高，反映市场对出口突破与资金用途高度认可","listText":"<a href=\"https://laohu8.com/S/02533\">$黑芝麻智能(02533)$&nbsp;</a> 上周看9号数据融资买入2180万元，为近半年单日最高，反映市场对出口突破与资金用途高度认可","text":"$黑芝麻智能(02533)$ 上周看9号数据融资买入2180万元，为近半年单日最高，反映市场对出口突破与资金用途高度认可","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/521667114279256","isVote":1,"tweetType":1,"viewCount":130,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":519525079913888,"gmtCreate":1767858462229,"gmtModify":1767858464246,"author":{"id":"4193625296607780","authorId":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4193625296607780","idStr":"4193625296607780"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/01055\">$中国南方航空股份(01055)$ </a> 随时有可能会来个向上爆发","listText":"<a href=\"https://laohu8.com/S/01055\">$中国南方航空股份(01055)$ </a> 随时有可能会来个向上爆发","text":"$中国南方航空股份(01055)$ 随时有可能会来个向上爆发","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/519525079913888","isVote":1,"tweetType":1,"viewCount":149,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":519525031703920,"gmtCreate":1767858425139,"gmtModify":1767858427400,"author":{"id":"4193625296607780","authorId":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4193625296607780","idStr":"4193625296607780"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 冻干人用狂犬病疫苗III期试验持续推进，覆盖Essen、Zagreb及简易四针方案，研发进入关键数阶段","listText":"<a href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$ </a> 冻干人用狂犬病疫苗III期试验持续推进，覆盖Essen、Zagreb及简易四针方案，研发进入关键数阶段","text":"$中慧生物-B(02627)$ 冻干人用狂犬病疫苗III期试验持续推进，覆盖Essen、Zagreb及简易四针方案，研发进入关键数阶段","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/519525031703920","isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":518716563709976,"gmtCreate":1767669077447,"gmtModify":1767669079627,"author":{"id":"4193625296607780","authorId":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4193625296607780","idStr":"4193625296607780"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/BKKT\">$Bakkt Holdings, Inc.(BKKT)$ </a> 触底必须得反弹","listText":"<a href=\"https://laohu8.com/S/BKKT\">$Bakkt Holdings, Inc.(BKKT)$ </a> 触底必须得反弹","text":"$Bakkt Holdings, Inc.(BKKT)$ 触底必须得反弹","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/518716563709976","isVote":1,"tweetType":1,"viewCount":146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":518727790297160,"gmtCreate":1767669035074,"gmtModify":1767669037160,"author":{"id":"4193625296607780","authorId":"4193625296607780","name":"打铁不如李铁","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4193625296607780","idStr":"4193625296607780"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 2025年，中国医药健康领域迎来从“量变”到“质变”的关键跃升，是政策、技术与产业协同成效，AI制药打破研发“不可能三角”，晶泰2026将迎来史上最佳发展时机","listText":"<a href=\"https://laohu8.com/S/02228\">$晶泰控股(02228)$ </a> 2025年，中国医药健康领域迎来从“量变”到“质变”的关键跃升，是政策、技术与产业协同成效，AI制药打破研发“不可能三角”，晶泰2026将迎来史上最佳发展时机","text":"$晶泰控股(02228)$ 2025年，中国医药健康领域迎来从“量变”到“质变”的关键跃升，是政策、技术与产业协同成效，AI制药打破研发“不可能三角”，晶泰2026将迎来史上最佳发展时机","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/518727790297160","isVote":1,"tweetType":1,"viewCount":441,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"following","isTTM":false}